These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The use of immunotherapy for the treatment of tuberculosis. Ramos-Espinosa O, Islas-Weinstein L, Peralta-Álvarez MP, López-Torres MO, Hernández-Pando R. Expert Rev Respir Med; 2018 May; 12(5):427-440. PubMed ID: 29575946 [Abstract] [Full Text] [Related]
24. Editorial: Advances in Immunotherapeutic Approaches to Tuberculosis. Estrada García I, Hernández Pando R, Ivanyi J. Front Immunol; 2021 May; 12():684200. PubMed ID: 33968090 [No Abstract] [Full Text] [Related]
26. [Specific and non-specific response of the body during the treatment of children with tuberculosis]. Sokurenko LS. Sov Zdravookhr Kirg; 1971 May; 4():7-10. PubMed ID: 5317313 [No Abstract] [Full Text] [Related]
28. Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83. Yu DH, Hu XD, Cai H. Gene Ther; 2008 May; 15(9):652-9. PubMed ID: 18288210 [Abstract] [Full Text] [Related]
29. [Adoptive immunotherapy for pulmonary tuberculosis caused by multi-resistant bacteria using autologous peripheral blood leucocytes sensitized with killed Mycobacterium tuberculosis bacteria]. Kitsukawa K, Higa F, Takushi Y, Miyagi H, Kakazu T, Fukuhara H, Nakamura H, Kaneshima H, Irabu Y, Shimoji K. Kekkaku; 1991 Sep; 66(9):563-75. PubMed ID: 1942728 [Abstract] [Full Text] [Related]
31. Th2-type immune response observed in healthy individuals to sonicate antigen prepared from the most prevalent Mycobacterium tuberculosis strain with single copy of IS6110. Rajavelu P, Das SD. FEMS Immunol Med Microbiol; 2005 Jul 01; 45(1):95-102. PubMed ID: 15985228 [Abstract] [Full Text] [Related]
33. [Immunotherapeutic efficacy of BCG vaccine in pulmonary tuberculosis and its preventive effect on multidrug-resistant tuberculosis]. Lei JP, Xiong GL, Hu QF, Li Y, Zong PL, Tu SH, Tu RY. Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Feb 01; 42(2):86-9. PubMed ID: 18642658 [Abstract] [Full Text] [Related]
34. The inflammatory response in Mycobacterium tuberculosis infection. Toossi Z. Arch Immunol Ther Exp (Warsz); 2000 Feb 01; 48(6):513-9. PubMed ID: 11197606 [Abstract] [Full Text] [Related]
36. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis]. Wang W, Jin G, Ye Y, Xia X, Wang A, Zhuang Y, Li G, Sun H, Wang Z, Lin M, Chen H, Li J, Dan Z, Zhang X. Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb 01; 22(2):108-10. PubMed ID: 11820954 [Abstract] [Full Text] [Related]
37. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Thorax; 2008 Jul 01; 63(7):627-34. PubMed ID: 18250184 [Abstract] [Full Text] [Related]